Exhibition

Company Profile Company Strength Exhibition FAQ

Our Exhibition

CPHI Europe、CPHI China、TIHE、VIF world 2025、CPHI Middle East





News Recommendations

Subjects was Grouped for Clinical Test on the Quadrivalent Meningococcal Conjugate Vaccine (MCV4) — Another Key Product of AIM Vaccine

Subjects was Grouped for Clinical Test on the Quadrivalent Meningococcal Conjugate Vaccine (MCV4) — Another Key Product of AIM Vaccine View More >>

Humoral and Cellular Immunity of The Mrna Rsv Vaccine Were Significantly Higher Than Those of Internationally Marketed Products Application for Clinical Trial in The U.S.

Humoral and Cellular Immunity of The Mrna Rsv Vaccine Were Significantly Higher Than Those of Internationally Marketed Products Application for Clinical Trial in The U.S.View More >>

What Is Rabies Vaccine Vero Cell and Why Is It Essential for Modern Rabies Prevention?

What Is Rabies Vaccine Vero Cell and Why Is It Essential for Modern Rabies Prevention?View More >>

Phase II Clinical Data on AIM’s mRNA Impressive and Significantly Effective On Omicron

Phase II Clinical Data on AIM’s mRNA Impressive and Significantly Effective On Omicron View More >>

AIM Vaccine Publishes the Latest Preclinical Data of mRNA Rabies Vaccine in

AIM Vaccine Publishes the Latest Preclinical Data of mRNA Rabies Vaccine in "npj Vaccines": Only Two Doses are Needed to Provide 100% Safe and Effective Immune Protection View More >>

E-mail

AIM Vaccine

X

We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy

Reject Accept